GLP-1 Drugs Show Promise Against Obesity-Linked Leukemia
New research suggests that GLP-1 receptor agonists, commonly prescribed for diabetes and weight loss, could be pivotal in a novel dual therapy to combat leukemia exacerbated by obesity.
Category
Search Results for
Latest stories, in-depth analysis & breaking updates
2+
Articles
The Quantified Self — How Tech is Reprogramming Fitness and Wellness
For decades, the fitness industry was defined by a culture of exertion and guesswork. You lifted heavy things, ran until you were exhausted, and hoped the mirror or the scale eventually reflected your...
